메뉴 건너뛰기




Volumn 454, Issue 1, 2013, Pages 539-552

Strategies for the design of orally bioavailable antileishmanial treatments

Author keywords

Drug combinations; Nanoparticles; Oral administration; Visceral leishmaniasis

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; DAPSONE; IMIDAZOLE DERIVATIVE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE; SITAMAQUINE; TRIAZOLE DERIVATIVE;

EID: 84884156394     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.07.035     Document Type: Review
Times cited : (50)

References (233)
  • 1
    • 0027139351 scopus 로고
    • Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B
    • Adler-Moore, J.P., Proffitt, R.T., 1993. Development, characterization, efficacy and mode of action of ambisome, a unilamellar liposomal formulation of amphotericin B. J. Liposome Res. 3, 429-450. (Pubitemid 24007409)
    • (1993) Journal of Liposome Research , vol.3 , Issue.3 , pp. 429-450
    • Adler-Moore, J.P.1    Proffitt, R.T.2
  • 2
    • 0032763329 scopus 로고    scopus 로고
    • Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases
    • Al-Abdely, H.M., Graybill, J.R., Loebenberg, D., Melby, P.C., 1999. Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases. Antimicrob. Agents Chemother. 43, 2910-2914.
    • (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 2910-2914
    • Al-Abdely, H.M.1    Graybill, J.R.2    Loebenberg, D.3    Melby, P.C.4
  • 4
    • 34547899919 scopus 로고    scopus 로고
    • Solid lipid nanoparticles as a drug delivery system for peptides and proteins
    • DOI 10.1016/j.addr.2007.04.007, PII S0169409X07000439, Lipid Nanoparticles: Recent Advances
    • Almeida, A.J., Souto, E., 2007. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv. Drug Deliv. Rev. 59, 478-490. (Pubitemid 47260710)
    • (2007) Advanced Drug Delivery Reviews , vol.59 , Issue.6 , pp. 478-490
    • Almeida, A.J.1    Souto, E.2
  • 6
    • 33646823616 scopus 로고    scopus 로고
    • Chemotherapy in the Treatment and Control of Leishmaniasis
    • Academic Press, London
    • Alvar, J., Croft, S., Olliaro, P., David, H.M., 2006. Chemotherapy in the Treatment and Control of Leishmaniasis, Advances in Parasitology. Academic Press, London, pp. 223-274.
    • (2006) Advances in Parasitology , pp. 223-274
    • Alvar, J.1    Croft, S.2    Olliaro, P.3    David, H.M.4
  • 7
    • 0021089252 scopus 로고
    • Delivery of liposome-encapsulated drugs to macrophages
    • Alving, C.R., 1983. Delivery of liposome-encapsulated drugs to macrophages. Pharmacol. Ther. 22, 407-424. (Pubitemid 14201457)
    • (1983) Pharmacology and Therapeutics , vol.22 , Issue.3 , pp. 407-424
    • Alving, C.R.1
  • 8
    • 45849094442 scopus 로고    scopus 로고
    • Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: Development and characterization
    • DOI 10.1166/jbn.2007.029
    • Amarji, B., Ajazuddin Raghuwanshi, D., Vyas, S.P., Kanaujia, P., 2007. Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: development and characterization. J. Biomed. Nanotechnol. 3, 264-269. (Pubitemid 351877152)
    • (2007) Journal of Biomedical Nanotechnology , vol.3 , Issue.3 , pp. 264-269
    • Amarji, B.1    Ajazuddin2    Raghuwanshi, D.3    Vyas, S.P.4    Kanaujia, P.5
  • 9
    • 0028948839 scopus 로고
    • A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
    • Amidon, G., Lennernäs, H., Shah, V., Crison, J., 1995. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12, 413-420.
    • (1995) Pharm. Res. , vol.12 , pp. 413-420
    • Amidon, G.1    Lennernäs, H.2    Shah, V.3    Crison, J.4
  • 10
    • 0035121778 scopus 로고    scopus 로고
    • Nouvelles formes lipidiques de l'amphotéricine B. Revue de la littérature
    • Andrès, E., Tiphine, M., Letscher-Bru, V., Herbrecht, R., 2001. Nouvelles formes lipidiques de l'Amphotericine B. Revue de la littérature. La Revue de Médecine Interne 22, 141-150. (Pubitemid 32154333)
    • (2001) Revue de Medecine Interne , vol.22 , Issue.2 , pp. 141-150
    • Andres, E.1    Tiphine, M.2    Letscher-Bru, V.3    Herbrecht, R.4
  • 11
    • 70349921511 scopus 로고    scopus 로고
    • Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules
    • Anton, N., Saulnier, P., Gaillard, C., Porcher, E., Vrignaud, S., Benoit, J.P., 2009. Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules. Langmuir 25, 11413-11419.
    • (2009) Langmuir , vol.25 , pp. 11413-11419
    • Anton, N.1    Saulnier, P.2    Gaillard, C.3    Porcher, E.4    Vrignaud, S.5    Benoit, J.P.6
  • 12
    • 28844499143 scopus 로고    scopus 로고
    • Lipid formulations of amphotericin B: Where are we today?
    • DOI 10.1016/j.mycmed.2005.06.005, PII S1156523305000776
    • Antoniadou, A., Dupont, B., 2005. Lipid formulations of amphotericin B: where are we today? J. Med. Mycol. 15, 230-238. (Pubitemid 41774269)
    • (2005) Journal de Mycologie Medicale , vol.15 , Issue.4 , pp. 230-238
    • Antoniadou, A.1    Dupont, B.2
  • 13
    • 0028071051 scopus 로고
    • Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2)
    • DOI 10.1023/A:1018967116988
    • Artursson, P., Lindmark, T., Davis, S.S., Illum, L., 1994. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11, 1358-1361. (Pubitemid 24287420)
    • (1994) Pharmaceutical Research , vol.11 , Issue.9 , pp. 1358-1361
    • Artursson, P.1    Lindmark, T.2    Davis, S.S.3    Illum, L.4
  • 14
    • 0030704614 scopus 로고    scopus 로고
    • The leishmaniases as model zoonoses
    • DOI 10.1080/00034989760428
    • Ashford, R.W., 1997. The leishmaniases as model zoonoses. Ann. Trop. Med. Parasitol. 91, 693-701. (Pubitemid 27480434)
    • (1997) Annals of Tropical Medicine and Parasitology , vol.91 , Issue.7 , pp. 693-701
    • Ashford, R.W.1
  • 15
    • 33847219040 scopus 로고    scopus 로고
    • Molecular mechanisms of antimony resistance in leishmania
    • Ashutosh Sundar, S., Goyal, N., 2007. Molecular mechanisms of antimony resistance in leishmania. J. Med. Microbiol. 56, 143-153.
    • (2007) J. Med. Microbiol. , vol.56 , pp. 143-153
    • Ashutosh Sundar, S.1    Goyal, N.2
  • 16
    • 84875148599 scopus 로고    scopus 로고
    • Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B encapsulated nano-emulsion template based chitosan nanocapsules
    • Asthana, S., Jaiswal, A.K., Gupta, P.K., Pawar, V.K., Dube, A., Chourasia, M.K., 2013. Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B encapsulated nano-emulsion template based chitosan nanocapsules. Antimicrob. Agents Chemother. 57, 1714-1722.
    • (2013) Antimicrob. Agents Chemother. , vol.57 , pp. 1714-1722
    • Asthana, S.1    Jaiswal, A.K.2    Gupta, P.K.3    Pawar, V.K.4    Dube, A.5    Chourasia, M.K.6
  • 17
    • 0032053990 scopus 로고    scopus 로고
    • The pharmacology of leishmaniasis
    • DOI 10.1016/S0306-3623(97)00268-1, PII S0306362397002681
    • Balaña-Fouce, R., Reguera, R.M., Cubría, J.C., Ordóñez, D., 1998. The pharmacology of leishmaniasis. Gen. Pharmacol. Vasc. Syst. 30, 435-443. (Pubitemid 28102818)
    • (1998) General Pharmacology , vol.30 , Issue.4 , pp. 435-443
    • Balana-Fouce, R.1    Reguera, R.M.2    Cubria, J.C.3    Ordonez, D.4
  • 19
    • 0030179394 scopus 로고    scopus 로고
    • Drug delivery system: Targeting of pentamidines to specific sites using sugar grafted liposomes
    • Banerjee, G., Nandi, G., Mahato, S.B., Pakrashi, A., Basu, M.K., 1996. Drug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomes. J. Antimicrob. Chemother. 38, 145-150. (Pubitemid 126449219)
    • (1996) Journal of Antimicrobial Chemotherapy , vol.38 , Issue.1 , pp. 145-150
    • Banerjee, G.1    Nandi, G.2    Mahato, S.B.3    Pakrashi, A.4    Basu, M.K.5
  • 20
    • 70350787689 scopus 로고    scopus 로고
    • Optimizing efficacy of Amphotericin B through nanomodification
    • Barratt, G., Bretagne, S., 2007. Optimizing efficacy of amphotericin B through nanomodification. Int. J. Nanomed. 2, 301-313. (Pubitemid 350047775)
    • (2007) International Journal of Nanomedicine , vol.2 , Issue.3 , pp. 301-313
    • Barratt, G.1    Bretagne, S.2
  • 21
    • 0036894232 scopus 로고    scopus 로고
    • Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion
    • DOI 10.1128/AAC.46.12.3731-3738.2002
    • Basselin, M., Denise, H., Coombs, G.H., Barrett, M.P., 2002. Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion. Antimicrob. Agents Chemother. 46, 3731-3738. (Pubitemid 35403244)
    • (2002) Antimicrobial Agents and Chemotherapy , vol.46 , Issue.12 , pp. 3731-3738
    • Basselin, M.1    Denise, H.2    Coombs, G.H.3    Barrett, M.P.4
  • 22
    • 4444272379 scopus 로고    scopus 로고
    • Macrophage specific drug delivery in experimental leishmaniasis
    • DOI 10.2174/1566524043360186
    • Basu, M.K., Lala, S., 2004. Macrophage specific drug delivery in experimental leishmaniasis. Curr. Mol. Med. 4, 681-689. (Pubitemid 39172370)
    • (2004) Current Molecular Medicine , vol.4 , Issue.6 , pp. 681-689
    • Basu, M.K.1    Lala, S.2
  • 25
    • 13544254608 scopus 로고    scopus 로고
    • Recent developments in leishmaniasis: Epidemiology, diagnosis, and treatment
    • Berman, J., 2005. Recent developments in leishmaniasis: epidemiology, diagnosis, and treatment. Curr. Infect. Dis. Rep. 7, 33-38. (Pubitemid 40220526)
    • (2005) Current Infectious Disease Reports , vol.7 , Issue.1 , pp. 33-38
    • Berman, J.1
  • 26
    • 0024004690 scopus 로고
    • Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies
    • Berman, J.D., 1988. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies. Rev. Infect. Dis. 10, 560-586.
    • (1988) Rev. Infect. Dis. , vol.10 , pp. 560-586
    • Berman, J.D.1
  • 27
    • 0030940539 scopus 로고    scopus 로고
    • Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
    • Berman, J.D., 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24, 684-703. (Pubitemid 27143564)
    • (1997) Clinical Infectious Diseases , vol.24 , Issue.4 , pp. 684-703
    • Berman, J.D.1
  • 31
    • 84876161904 scopus 로고    scopus 로고
    • Nanocarrier systems for oral drug delivery: Do we really need them?
    • Bernkop-Schnürch, A., 2013. Nanocarrier systems for oral drug delivery: do we really need them? Eur. J. Pharm. Sci. 49, 272-277.
    • (2013) Eur. J. Pharm. Sci. , vol.49 , pp. 272-277
    • Bernkop-Schnürch, A.1
  • 33
    • 0022862167 scopus 로고
    • How do the polyene macrolide antibiotics affect the cellular membrane properties?
    • Bolard, J., 1986. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim. Biophys. Acta 864, 257-304. (Pubitemid 17228111)
    • (1986) Biochimica et Biophysica Acta - Reviews on Biomembranes , vol.864 , Issue.3-4 , pp. 257-304
    • Bolard, J.1
  • 34
    • 0033093302 scopus 로고    scopus 로고
    • Epidemiology of visceral leishmaniasis in India
    • Bora, D., 1999. Epidemiology of visceral leishmaniasis in India. Natl. Med. J. India 12, 62-68.
    • (1999) Natl. Med. J. India , vol.12 , pp. 62-68
    • Bora, D.1
  • 35
    • 40749149204 scopus 로고    scopus 로고
    • Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani
    • DOI 10.1016/j.biopha.2007.12.006, PII S0753332207002892
    • Bories, C., Cojean, S., Huteau, F., Loiseau, P.M., 2008. Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani. Biomed. Pharmacother. 62, 164-167. (Pubitemid 351381937)
    • (2008) Biomedicine and Pharmacotherapy , vol.62 , Issue.3 , pp. 164-167
    • Bories, C.1    Cojean, S.2    Huteau, F.3    Loiseau, P.M.4
  • 36
    • 31144457181 scopus 로고    scopus 로고
    • Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems
    • DOI 10.1016/j.ijpharm.2005.11.033, PII S0378517305008069
    • Boyd, B.J., Whittaker, D.V., Khoo, S.M., Davey, G., 2006. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int. J. Pharm. 309, 218-226. (Pubitemid 43129485)
    • (2006) International Journal of Pharmaceutics , vol.309 , Issue.1-2 , pp. 218-226
    • Boyd, B.J.1    Whittaker, D.V.2    Khoo, S.-M.3    Davey, G.4
  • 38
    • 0038742717 scopus 로고    scopus 로고
    • Pentamidine uptake and resistance in pathogenic protozoa: Past, present and future
    • DOI 10.1016/S1471-4922(03)00069-2
    • Bray, P.G., Barrett, M.P., Ward, S.A., de Koning, H.P., 2003. Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol. 19, 232-239. (Pubitemid 36588598)
    • (2003) Trends in Parasitology , vol.19 , Issue.5 , pp. 232-239
    • Bray, P.G.1    Barrett, M.P.2    Ward, S.A.3    De Koning, H.P.4
  • 39
    • 0035161541 scopus 로고    scopus 로고
    • Current issues in the treatment of visceral leishmaniasis
    • Bryceson, A., 2001a. Current issues in the treatment of visceral leishmaniasis. Med. Microbiol. Immunol. 190, 81-84. (Pubitemid 33079365)
    • (2001) Medical Microbiology and Immunology , vol.190 , Issue.1-2 , pp. 81-84
    • Bryceson, A.1
  • 40
    • 0034772197 scopus 로고    scopus 로고
    • A policy for leishmaniasis with respect to the prevention and control of drug resistance
    • DOI 10.1046/j.1365-3156.2001.00795.x
    • Bryceson, A., 2001b. A policy for leishmaniasis with respect to the prevention and control of drug resistance. Trop. Med. Int. Health 6, 928-934. (Pubitemid 33010880)
    • (2001) Tropical Medicine and International Health , vol.6 , Issue.11 , pp. 928-934
    • Bryceson, A.1
  • 41
    • 80051817554 scopus 로고    scopus 로고
    • The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase
    • Carvalho, L., Luque-Ortega, J.R., Lopez-Martin, C., Castanys, S., Rivas, L., Gamarro, F., 2011. The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase. Antimicrob. Agents Chemother. 55, 4204-4210.
    • (2011) Antimicrob. Agents Chemother. , vol.55 , pp. 4204-4210
    • Carvalho, L.1    Luque-Ortega, J.R.2    Lopez-Martin, C.3    Castanys, S.4    Rivas, L.5    Gamarro, F.6
  • 42
    • 0035543633 scopus 로고    scopus 로고
    • Plant natural products with leishmanicidal activity
    • DOI 10.1039/b100455g
    • Chan-Bacab, M.J., Pena-Rodriguez, L.M., 2001. Plant natural products with leishmanicidal activity. Nat. Prod. Rep. 18, 674-688. (Pubitemid 34010018)
    • (2001) Natural Product Reports , vol.18 , Issue.6 , pp. 674-688
    • Chan-Bacab, M.J.1    Pena-Rodriguez, L.M.2
  • 45
    • 0036211404 scopus 로고    scopus 로고
    • Self-assembled nanocubicle as a carrier for peroral insulin delivery
    • DOI 10.1007/s00125-001-0751-z
    • Chung, H., Kim, J., Um, J.Y., Kwon, I.C., Jeong, S.Y., 2002. Self-assembled nanocubicle as a carrier for peroral insulin delivery. Diabetologia 45, 448-451. (Pubitemid 34267369)
    • (2002) Diabetologia , vol.45 , Issue.3 , pp. 448-451
    • Chung, H.1    Kim, J.2    Um, J.Y.3    Kwon, I.C.4    Jeong, S.Y.5
  • 47
    • 0027590737 scopus 로고
    • Nano- and microparticles for the delivery of polypeptides and proteins
    • Couvreur, P., Puisieux, F., 1993. Nano- and microparticles for the delivery of polypeptides and proteins. Adv. Drug Deliv. Rev. 10, 141-162. (Pubitemid 23172580)
    • (1993) Advanced Drug Delivery Reviews , vol.10 , Issue.2-3 , pp. 141-162
    • Couvreur, P.1    Puisieux, F.2
  • 48
    • 0017730504 scopus 로고
    • Nanocapsules: A new type of lysosomotropic carrier
    • DOI 10.1016/0014-5793(77)80717-5
    • Couvreur, P., Tulkens, P., Roland, M., Trouet, A., Speiser, P., 1977. Nanocapsules: a new type of lysosomotropic carrier. FEBS Lett. 84, 323-326. (Pubitemid 8246984)
    • (1977) FEBS Letters , vol.84 , Issue.2 , pp. 323-326
    • Couvreur, P.1    Tulkens, P.2    Roland, M.3
  • 49
    • 0142258171 scopus 로고    scopus 로고
    • Leishmaniasis - Current chemotherapy and recent advances in the search for novel drugs
    • DOI 10.1016/j.pt.2003.09.008
    • Croft, S.L., Coombs, G.H., 2003. Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol. 19, 502-508. (Pubitemid 37329659)
    • (2003) Trends in Parasitology , vol.19 , Issue.11 , pp. 502-508
    • Croft, S.L.1    Coombs, G.H.2
  • 50
    • 0023186694 scopus 로고
    • The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani
    • DOI 10.1016/0006-2952(87)90543-0
    • Croft, S.L., Neal, R.A., Pendergast, W., Chan, J.H., 1987. The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani. Biochem. Pharmacol. 36, 2633-2636. (Pubitemid 17102920)
    • (1987) Biochemical Pharmacology , vol.36 , Issue.16 , pp. 2633-2636
    • Croft, S.L.1    Neal, R.A.2    Pendergast, W.3    Chan, J.H.4
  • 51
  • 52
    • 0031809090 scopus 로고    scopus 로고
    • Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat
    • Dangi, J.S., Vyas, S.P., Dixit, V.K., 1998. Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat. Drug Dev. Ind. Pharm. 24, 631-635. (Pubitemid 28312300)
    • (1998) Drug Development and Industrial Pharmacy , vol.24 , Issue.7 , pp. 631-635
    • Dangi, J.S.1    Vyas, S.P.2    Dixit, V.K.3
  • 53
    • 0032438513 scopus 로고    scopus 로고
    • Practical guide for the treatment of leishmaniasis
    • DOI 10.2165/00003495-199856060-00005
    • Davidson, R.N., 1998. Practical guide for the treatment of leishmaniasis. Drugs 56, 1009-1018. (Pubitemid 29010219)
    • (1998) Drugs , vol.56 , Issue.6 , pp. 1009-1018
    • Davidson, R.N.1
  • 54
    • 0025872527 scopus 로고
    • Liposomal amphotericin B in drug-resistant visceral leishmaniasis
    • Davidson, R.N., Scott, A., Maini, M., Bryceson, A.D.M., Croft, S.L., 1991. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet 337, 1061-1062.
    • (1991) Lancet , vol.337 , pp. 1061-1062
    • Davidson, R.N.1    Scott, A.2    Maini, M.3    Bryceson, A.D.M.4    Croft, S.L.5
  • 55
    • 0035992021 scopus 로고    scopus 로고
    • Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis
    • DOI 10.1128/AAC.46.8.2704-2707.2002
    • Delmas, G., Park, S., Chen, Z.W., Tan, F., Kashiwazaki, R., Zarif, L., Perlin, D.S., 2002. Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis. Antimicrob. Agents Chemother. 46, 2704-2707. (Pubitemid 34793493)
    • (2002) Antimicrobial Agents and Chemotherapy , vol.46 , Issue.8 , pp. 2704-2707
    • Delmas, G.1    Park, S.2    Chen, Z.W.3    Tan, F.4    Kashiwazaki, R.5    Zarif, L.6    Perlin, D.S.7
  • 57
    • 0033193097 scopus 로고    scopus 로고
    • Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases)
    • Denerolle, P., Bourdoiseau, G., 1999. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). J. Vet. Intern. Med. 13, 413-415.
    • (1999) J. Vet. Intern. Med. , vol.13 , pp. 413-415
    • Denerolle, P.1    Bourdoiseau, G.2
  • 58
    • 0030249268 scopus 로고    scopus 로고
    • Leishmaniasis: Public health aspects and control
    • DOI 10.1016/0738-081X(96)00057-0
    • Desjeux, P., 1996. Leishmaniasis: public health aspects and control. Clin. Dermatol. 14, 417-423. (Pubitemid 26327735)
    • (1996) Clinics in Dermatology , vol.14 , Issue.5 , pp. 417-423
    • Desjeux, P.1
  • 59
    • 0014437227 scopus 로고
    • Nephrotoxic effects of amphotericin B, including renal tubular acidosis
    • Douglas, J.B., Healy, J.K., 1969. Nephrotoxic effects of amphotericin B, including renal tubular acidosis. Am. J. Med. 46, 154-162.
    • (1969) Am. J. Med. , vol.46 , pp. 154-162
    • Douglas, J.B.1    Healy, J.K.2
  • 60
    • 60449087425 scopus 로고    scopus 로고
    • Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin
    • Du, Y.Z., Wang, L., Yuan, H., Wei, X.H., Hu, F.Q., 2009. Preparation and characteristics of linoleic acid-grafted chitosan oligosaccharide micelles as a carrier for doxorubicin. Colloids Surf. B: Biointerfaces 69, 257-263.
    • (2009) Colloids Surf. B: Biointerfaces , vol.69 , pp. 257-263
    • Du, Y.Z.1    Wang, L.2    Yuan, H.3    Wei, X.H.4    Hu, F.Q.5
  • 61
    • 33846410660 scopus 로고    scopus 로고
    • Interaction of sitamaquine with membrane lipids of Leishmania donovani promastigotes
    • DOI 10.1016/j.bbamem.2006.07.003, PII S0005273606002628
    • Dueñas-Romero, A.M., Loiseau, P.M., Saint-Pierre-Chazalet, M., 2007. Interaction of sitamaquine with membrane lipids of Leishmania donovani promastigotes. Biochim. Biophys. Acta (BBA): Biomembr. 1768, 246-252. (Pubitemid 46138097)
    • (2007) Biochimica et Biophysica Acta - Biomembranes , vol.1768 , Issue.2 , pp. 246-252
    • Duenas-Romero, A.M.1    Loiseau, P.M.2    Saint-Pierre-Chazalet, M.3
  • 63
    • 0036968374 scopus 로고    scopus 로고
    • In vitro antileishmanial activity of amphotericin B loaded in poly(epsiloncaprolactone) nanospheres
    • Espuelas, M.S., Legrand, P., Loiseau, P.M., Bories, C., Barratt, G., Irache, J.M., 2002. In vitro antileishmanial activity of amphotericin B loaded in poly(epsiloncaprolactone) nanospheres. J. Drug Target. 10, 593-599.
    • (2002) J. Drug Target. , vol.10 , pp. 593-599
    • Espuelas, M.S.1    Legrand, P.2    Loiseau, P.M.3    Bories, C.4    Barratt, G.5    Irache, J.M.6
  • 64
    • 0036833567 scopus 로고    scopus 로고
    • Natural products as trypanocidal, antileishmanial and antimalarial drugs
    • Fournet, A., Munoz, V., 2002. Natural products as trypanocidal, antileishmanial and antimalarial drugs. Curr. Top. Med. Chem. 2, 1215-1237.
    • (2002) Curr. Top. Med. Chem. , vol.2 , pp. 1215-1237
    • Fournet, A.1    Munoz, V.2
  • 65
    • 68649102607 scopus 로고    scopus 로고
    • Pentavalent antimonials: New perspectives for old drugs
    • Frézard, F., Demicheli, C., Ribeiro, R., 2009. Pentavalent antimonials: new perspectives for old drugs. Molecules 14, 2317-2336.
    • (2009) Molecules , vol.14 , pp. 2317-2336
    • Frézard, F.1    Demicheli, C.2    Ribeiro, R.3
  • 67
    • 0026507069 scopus 로고
    • Drug targeting with polyalkylcyanoacrylate nanoparticles: In vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani
    • Gaspar, R., Opperdoes, F.R., Preat, V., Roland, M., 1992. Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani. Ann. Trop. Med. Parasitol. 86, 41-49.
    • (1992) Ann. Trop. Med. Parasitol. , vol.86 , pp. 41-49
    • Gaspar, R.1    Opperdoes, F.R.2    Preat, V.3    Roland, M.4
  • 68
    • 78149474474 scopus 로고    scopus 로고
    • Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009)
    • Gershkovich, P., Sivak, O., Wasan, E.K., Magil, A.B., Owen, D., Clement, J.G., Wasan, K.M., 2010. Biodistribution and tissue toxicity of amphotericin B in mice following multiple dose administration of a novel oral lipid-based formulation (iCo-009). J. Antimicrob. Chemother. 65, 2610-2613.
    • (2010) J. Antimicrob. Chemother. , vol.65 , pp. 2610-2613
    • Gershkovich, P.1    Sivak, O.2    Wasan, E.K.3    Magil, A.B.4    Owen, D.5    Clement, J.G.6    Wasan, K.M.7
  • 69
    • 67249101874 scopus 로고    scopus 로고
    • Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation
    • Gershkovich, P., Wasan, E.K., Lin, M., Sivak, O., Leon, C.G., Clement, J.G., Wasan, K.M., 2009. Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation. J. Antimicrob. Chemother. 64, 101-108.
    • (2009) J. Antimicrob. Chemother. , vol.64 , pp. 101-108
    • Gershkovich, P.1    Wasan, E.K.2    Lin, M.3    Sivak, O.4    Leon, C.G.5    Clement, J.G.6    Wasan, K.M.7
  • 70
    • 78650061557 scopus 로고    scopus 로고
    • Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization
    • Gilani, K., Moazeni, E., Ramezanli, T., Amini, M., Fazeli, M.R., Jamalifar, H., 2011. Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization. J. Pharm. Sci. 100, 252-259.
    • (2011) J. Pharm. Sci. , vol.100 , pp. 252-259
    • Gilani, K.1    Moazeni, E.2    Ramezanli, T.3    Amini, M.4    Fazeli, M.R.5    Jamalifar, H.6
  • 71
    • 0032085984 scopus 로고    scopus 로고
    • Use of allopurinol for maintenance of remission in dogs with leishmaniasis
    • Ginel, P.J., Lucena, R., Lopez, R., Molleda, J.M., 1998. Use of allopurinol for maintenance of remission in dogs with leishmaniasis. J. Small Anim. Pract. 39, 271-274. (Pubitemid 128527594)
    • (1998) Journal of Small Animal Practice , vol.39 , Issue.6 , pp. 271-274
    • Ginel, P.J.1    Lucena, R.2    Lopez, R.3    Molleda, J.M.4
  • 72
    • 85076867225 scopus 로고    scopus 로고
    • Modified chitosan hydrogels as drug delivery and tissue engineering systems: Present status and applications
    • Giri, T.K., Thakur, A., Alexander, A., Ajazuddin Badwaik, H., Tripathi, D.K., 2012. Modified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications. Acta Pharm. Sin. B 2, 439-449.
    • (2012) Acta Pharm. Sin. B , vol.2 , pp. 439-449
    • Giri, T.K.1    Thakur, A.2    Alexander, A.3    Ajazuddin Badwaik, H.4    Tripathi, D.K.5
  • 73
    • 0023935436 scopus 로고
    • Effect of the aggregation state of amphotericin B on its interaction with ergosterol
    • Gruda, I., Dussault, N., 1988. Effect of the aggregation state of amphotericin B on its interaction with ergosterol. Biochem. Cell Biol. 66, 177-183.
    • (1988) Biochem. Cell Biol. , vol.66 , pp. 177-183
    • Gruda, I.1    Dussault, N.2
  • 74
    • 0036319712 scopus 로고    scopus 로고
    • Visceral leishmaniasis: Current status of control, diagnosis, and treatment, and a proposed research and development agenda
    • DOI 10.1016/S1473-3099(02)00347-X
    • Guerin, P.J., Olliaro, P., Sundar, S., Boelaert, M., Croft, S.L., Desjeux, P., Wasunna, M.K., Bryceson, A.D.M., 2002. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect. Dis. 2, 494-501. (Pubitemid 34826855)
    • (2002) Lancet Infectious Diseases , vol.2 , Issue.8 , pp. 494-501
    • Guerin, P.J.1    Olliaro, P.2    Sundar, S.3    Boelaert, M.4    Croft, S.L.5    Desjeux, P.6    Wasunna, M.K.7    Bryceson, A.D.M.8
  • 75
    • 77749283311 scopus 로고    scopus 로고
    • Drug delivery strategies for therapy of visceral leishmaniasis
    • Gupta, S., Pal, A., Vyas, S.P., 2010. Drug delivery strategies for therapy of visceral leishmaniasis. Expert Opin. Drug Deliv. 7, 371-402.
    • (2010) Expert Opin. Drug Deliv. , vol.7 , pp. 371-402
    • Gupta, S.1    Pal, A.2    Vyas, S.P.3
  • 76
    • 84965094146 scopus 로고
    • An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man
    • discussion 231-212
    • Halde, C., Newcomer, V.D., Wright, E.T., Sternberg, T.H., 1957. An evaluation of amphotericin B in vitro and in vivo in mice against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man. J. Invest. Dermatol. 28, 217-231 (discussion 231-212).
    • (1957) J. Invest. Dermatol. , vol.28 , pp. 217-231
    • Halde, C.1    Newcomer, V.D.2    Wright, E.T.3    Sternberg, T.H.4
  • 77
    • 0030449320 scopus 로고    scopus 로고
    • Amphotericin B: New life for an old drug
    • DOI 10.1016/S0165-6147(96)01012-7
    • Hartsel, S., Bolard, J., 1996. Amphotericin B: new life for an old drug. Trends Pharmacol. Sci. 17, 445-449. (Pubitemid 27028476)
    • (1996) Trends in Pharmacological Sciences , vol.17 , Issue.12 , pp. 445-449
    • Hartsel, S.1    Bolard, J.2
  • 78
    • 0031914282 scopus 로고    scopus 로고
    • Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor
    • Hauss, D.J., Fogal, S.E., Ficorilli, J.V., Price, C.A., Roy, T., Jayaraj, A.A., Keirns, J.J., 1998. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci. 87, 164-169.
    • (1998) J. Pharm. Sci. , vol.87 , pp. 164-169
    • Hauss, D.J.1    Fogal, S.E.2    Ficorilli, J.V.3    Price, C.A.4    Roy, T.5    Jayaraj, A.A.6    Keirns, J.J.7
  • 79
    • 0021179518 scopus 로고
    • Quantitative and ultrastructural studies on the uptake of drug loaded liposomes by mononuclear phagocytes infected with Leishmania donovani
    • Heath, S., Chance, M.L., New, R.R.C., 1984. Quantitative and ultrastructural studies on the uptake of drug loaded liposomes by mononuclear phagocytes infected with Leishmania donovani. Mol. Biochem. Parasitol. 12, 49-60. (Pubitemid 14056236)
    • (1984) Molecular and Biochemical Parasitology , vol.12 , Issue.1 , pp. 49-60
    • Heath, S.1    Chance, M.L.2    New, R.R.C.3
  • 80
    • 0033517487 scopus 로고    scopus 로고
    • Leishmaniasis
    • DOI 10.1016/S0140-6736(98)10178-2
    • Herwaldt, B.L., 1999. Leishmaniasis. Lancet 354, 1191-1199. (Pubitemid 29460458)
    • (1999) Lancet , vol.354 , Issue.9185 , pp. 1191-1199
    • Herwaldt, B.L.1
  • 81
    • 0026729038 scopus 로고
    • Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies
    • Herwaldt, B.L., Berman, J.D., 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am. J. Trop. Med. Hyg. 46, 296-306.
    • (1992) Am. J. Trop. Med. Hyg. , vol.46 , pp. 296-306
    • Herwaldt, B.L.1    Berman, J.D.2
  • 82
    • 0036297426 scopus 로고    scopus 로고
    • A novel phase inversion-based process for the preparation of lipid nanocarriers
    • DOI 10.1023/A:1016121319668
    • Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., 2002. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19, 875-880. (Pubitemid 34692585)
    • (2002) Pharmaceutical Research , vol.19 , Issue.6 , pp. 875-880
    • Heurtault, B.1    Saulnier, P.2    Pech, B.3    Proust, J.-E.4    Benoit, J.-P.5
  • 84
    • 84865283547 scopus 로고    scopus 로고
    • Efficacy and toxicity of a tropically stable lipid-based formulation of amphotericin B (iCo-010) in a rat model of invasive candidiasis
    • Ibrahim, F., Gershkovich, P., Sivak, O., Wasan, E.K., Bartlett, K., Wasan, K.M., 2012a. Efficacy and toxicity of a tropically stable lipid-based formulation of amphotericin B (iCo-010) in a rat model of invasive candidiasis. Int. J. Pharm. 436, 318-323.
    • (2012) Int. J. Pharm. , vol.436 , pp. 318-323
    • Ibrahim, F.1    Gershkovich, P.2    Sivak, O.3    Wasan, E.K.4    Bartlett, K.5    Wasan, K.M.6
  • 85
    • 84861194541 scopus 로고    scopus 로고
    • Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model
    • Ibrahim, F., Gershkovich, P., Sivak, O., Wasan, E.K., Wasan, K.M., 2012b. Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model. Eur. J. Pharm. Sci. 46, 323-328.
    • (2012) Eur. J. Pharm. Sci. , vol.46 , pp. 323-328
    • Ibrahim, F.1    Gershkovich, P.2    Sivak, O.3    Wasan, E.K.4    Wasan, K.M.5
  • 86
    • 0031783879 scopus 로고    scopus 로고
    • Chitosan and its use as a pharmaceutical excipient
    • DOI 10.1023/A:1011929016601
    • Illum, L., 1998. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15, 1326-1331. (Pubitemid 28427917)
    • (1998) Pharmaceutical Research , vol.15 , Issue.9 , pp. 1326-1331
    • Illum, L.1
  • 87
    • 84865136915 scopus 로고    scopus 로고
    • Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis
    • Italia, J.L., Kumar, M.N., Carter, K.C., 2012. Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis. J. Biomed. Nanotechnol. 8, 695-702.
    • (2012) J. Biomed. Nanotechnol. , vol.8 , pp. 695-702
    • Italia, J.L.1    Kumar, M.N.2    Carter, K.C.3
  • 88
    • 80053613500 scopus 로고    scopus 로고
    • Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™
    • Italia, J.L., Sharp, A., Carter, K.C., Warn, P., Kumar, M.N.V.R., 2011. Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™. PLoS ONE 6, e25744.
    • (2011) PLoS ONE , vol.6
    • Italia, J.L.1    Sharp, A.2    Carter, K.C.3    Warn, P.4    Kumar, M.N.V.R.5
  • 89
    • 67349276996 scopus 로고    scopus 로고
    • Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous fungizone
    • Italia, J.L., Yahya, M.M., Singh, D., Ravi Kumar, M.N., 2009. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous fungizone. Pharm. Res. 26, 1324-1331.
    • (2009) Pharm. Res. , vol.26 , pp. 1324-1331
    • Italia, J.L.1    Yahya, M.M.2    Singh, D.3    Ravi Kumar, M.N.4
  • 90
    • 84865966794 scopus 로고    scopus 로고
    • Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B
    • Jain, S., Valvi, P.U., Swarnakar, N.K., Thanki, K., 2012. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B. Mol. Pharm. 9, 2542-2553.
    • (2012) Mol. Pharm. , vol.9 , pp. 2542-2553
    • Jain, S.1    Valvi, P.U.2    Swarnakar, N.K.3    Thanki, K.4
  • 96
    • 0026514067 scopus 로고
    • Inhibiting cholesterol synthesis reduces the binding and toxicity of amphotericin B against rabbit renal tubular cells in primary culture
    • Joly, V., Saint-Pierre-Chazalet, M., Saint-Julien, L., Bolard, J., Carbon, C., Yeni, P., 1992. Inhibiting cholesterol synthesis reduces the binding and toxicity of amphotericin B against rabbit renal tubular cells in primary culture. J. Infect. Dis. 165, 337-343.
    • (1992) J. Infect. Dis. , vol.165 , pp. 337-343
    • Joly, V.1    Saint-Pierre-Chazalet, M.2    Saint-Julien, L.3    Bolard, J.4    Carbon, C.5    Yeni, P.6
  • 97
    • 80054697161 scopus 로고    scopus 로고
    • Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications
    • Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., Onoue, S., 2011. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int. J. Pharm. 420, 1-10.
    • (2011) Int. J. Pharm. , vol.420 , pp. 1-10
    • Kawabata, Y.1    Wada, K.2    Nakatani, M.3    Yamada, S.4    Onoue, S.5
  • 98
    • 0033970268 scopus 로고    scopus 로고
    • Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against Leishmania infected macrophages
    • DOI 10.1016/S0378-5173(99)00434-2, PII S0378517399004342
    • Kayser, O., 2000. Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages. Int. J. Pharm. 196, 253-256. (Pubitemid 30105755)
    • (2000) International Journal of Pharmaceutics , vol.196 , Issue.2 , pp. 253-256
    • Kayser, O.1
  • 100
    • 33846847777 scopus 로고    scopus 로고
    • Leishmania vaccines: Progress and problems
    • DOI 10.1017/S0031182006001831, PII S0031182006001831
    • Kedzierski, L., Zhu, Y., Handman, E., 2006. Leishmania vaccines: progress and problems. Parasitology 133 (Suppl.), S87-S112. (Pubitemid 46208033)
    • (2006) Parasitology , vol.133 , Issue.SUPPL.2
    • Kedzierski, L.1    Zhu, Y.2    Handman, E.3
  • 101
    • 34548049483 scopus 로고    scopus 로고
    • Nanosizing - Oral formulation development and biopharmaceutical evaluation
    • DOI 10.1016/j.addr.2007.05.003, PII S0169409X0700083X
    • Kesisoglou, F., Panmai, S., Wu, Y., 2007. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 59, 631-644. (Pubitemid 47285408)
    • (2007) Advanced Drug Delivery Reviews , vol.59 , Issue.7 , pp. 631-644
    • Kesisoglou, F.1    Panmai, S.2    Wu, Y.3
  • 102
    • 0043212012 scopus 로고    scopus 로고
    • Polymeric microspheres for drug delivery to the oral cavity: An in vitro evaluation of mucoadhesive potential
    • DOI 10.1002/jps.10423
    • Kockisch, S., Rees, G.D., Young, S.A., Tsibouklis, J., Smart, J.D., 2003. Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential. J. Pharm. Sci. 92, 1614-1623. (Pubitemid 36929681)
    • (2003) Journal of Pharmaceutical Sciences , vol.92 , Issue.8 , pp. 1614-1623
    • Kockisch, S.1    Rees, G.D.2    Young, S.A.3    Tsibouklis, J.4    Smart, J.D.5
  • 103
    • 84859947948 scopus 로고    scopus 로고
    • Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs
    • Kotta, S., Khan, A.W., Pramod, K., Ansari, S.H., Sharma, R.K., Ali, J., 2012. Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs. Expert Opin. Drug Deliv. 9, 585-598.
    • (2012) Expert Opin. Drug Deliv. , vol.9 , pp. 585-598
    • Kotta, S.1    Khan, A.W.2    Pramod, K.3    Ansari, S.H.4    Sharma, R.K.5    Ali, J.6
  • 105
    • 0025774705 scopus 로고
    • Liposomes and nanoparticles as vehicles for antibiotics
    • Kreuter, J., 1991. Liposomes and nanoparticles as vehicles for antibiotics. Infection 19, S224-S228.
    • (1991) Infection , vol.19
    • Kreuter, J.1
  • 109
    • 3042844195 scopus 로고    scopus 로고
    • Harmine: Evaluation of its antileishmanial properties in various vesicular delivery systems
    • Lala, S., Pramanick, S., Mukhopadhyay, S., Bandyopadhyay, S., Basu, M.K., 2004. Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems. J. Drug Target. 12, 165-175.
    • (2004) J. Drug Target. , vol.12 , pp. 165-175
    • Lala, S.1    Pramanick, S.2    Mukhopadhyay, S.3    Bandyopadhyay, S.4    Basu, M.K.5
  • 110
    • 0033840158 scopus 로고    scopus 로고
    • Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides
    • DOI 10.1023/A:1007582332491
    • Lambert, G., Fattal, E., Pinto-Alphandary, H., Gulik, A., Couvreur, P., 2000. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharm. Res. 17, 707-714. (Pubitemid 30670637)
    • (2000) Pharmaceutical Research , vol.17 , Issue.6 , pp. 707-714
    • Lambert, G.1    Fattal, E.2    Pinto-Alphandary, H.3    Gulik, A.4    Couvreur, P.5
  • 111
    • 0017317645 scopus 로고
    • Polymers for the sustained release of proteins and other macromolecules
    • Langer, R., Folkman, J., 1976. Polymers for the sustained release of proteins and other macromolecules. Nature 263, 797-800.
    • (1976) Nature , vol.263 , pp. 797-800
    • Langer, R.1    Folkman, J.2
  • 114
    • 80051780560 scopus 로고    scopus 로고
    • In vitro cytotoxicity of two novel oral formulations of amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines
    • Leon, C.G., Lee, J., Bartlett, K., Gershkovich, P., Wasan, E.K., Zhao, J., Clement, J.G., Wasan, K.M., 2011. In vitro cytotoxicity of two novel oral formulations of amphotericin B (iCo-009 and iCo-010) against Candida albicans, human monocytic and kidney cell lines. Lipids Health Dis. 10, 144.
    • (2011) Lipids Health Dis. , vol.10 , pp. 144
    • Leon, C.G.1    Lee, J.2    Bartlett, K.3    Gershkovich, P.4    Wasan, E.K.5    Zhao, J.6    Clement, J.G.7    Wasan, K.M.8
  • 115
    • 0033509735 scopus 로고    scopus 로고
    • Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani
    • Lira, R., Sundar, S., Makharia, A., Kenney, R., Gam, A., Saraiva, E., Sacks, D., 1999. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J. Infect. Dis. 180, 564-567.
    • (1999) J. Infect. Dis. , vol.180 , pp. 564-567
    • Lira, R.1    Sundar, S.2    Makharia, A.3    Kenney, R.4    Gam, A.5    Saraiva, E.6    Sacks, D.7
  • 116
    • 12644252548 scopus 로고
    • Coccidioidomycosis and its treatment with amphotericin B
    • Littman, M.L., Horowitz, P.L., Swadey, J.G., 1958. Coccidioidomycosis and its treatment with amphotericin B. Am. J. Med. 24, 568-592.
    • (1958) Am. J. Med. , vol.24 , pp. 568-592
    • Littman, M.L.1    Horowitz, P.L.2    Swadey, J.G.3
  • 119
    • 0001417138 scopus 로고
    • Some aspects of the absorption, distribution, and excretion of amphotericin B in man
    • Louria, D.B., 1958. Some aspects of the absorption, distribution, and excretion of amphotericin B in man. Antib. Med. Clin. Ther. 5, 295-301.
    • (1958) Antib. Med. Clin. Ther. , vol.5 , pp. 295-301
    • Louria, D.B.1
  • 120
    • 85028127551 scopus 로고    scopus 로고
    • Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs
    • Lu, Y., Park, K., 2012. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int. J. Pharm., http://dx.doi.org/ 10.1016/j.ijpharm.2012.08.042.
    • (2012) Int. J. Pharm.
    • Lu, Y.1    Park, K.2
  • 121
    • 0037446277 scopus 로고    scopus 로고
    • Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants
    • DOI 10.1016/S0021-9797(02)00016-4
    • Lynch, M.L., Ofori-Boateng, A., Hippe, A., Kochvar, K., Spicer, P.T., 2003. Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants. J. Colloids Interface Sci. 260, 404-413. (Pubitemid 36401600)
    • (2003) Journal of Colloid and Interface Science , vol.260 , Issue.2 , pp. 404-413
    • Lynch, M.L.1    Ofori-Boateng, A.2    Hippe, A.3    Kochvar, K.4    Spicer, P.T.5
  • 123
    • 0026076280 scopus 로고
    • Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis
    • Marr, J.J., 1991. Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. J. Lab. Clin. Med. 118, 111-119.
    • (1991) J. Lab. Clin. Med. , vol.118 , pp. 111-119
    • Marr, J.J.1
  • 125
    • 84905783840 scopus 로고    scopus 로고
    • Leishmaniasis: Clinical syndromes and treatment
    • McGwire, B.S., Satoskar, A.R., 2013. Leishmaniasis: clinical syndromes and treatment. QJM, http://dx.doi.org/10.1093/qjmed/hct116.
    • (2013) QJM
    • McGwire, B.S.1    Satoskar, A.R.2
  • 126
    • 0035946615 scopus 로고    scopus 로고
    • Solid lipid nanoparticles: Production, characterization and applications
    • DOI 10.1016/S0169-409X(01)00105-3, PII S0169409X01001053
    • Mehnert, W., Mäder, K., 2001. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47, 165-196. (Pubitemid 32324113)
    • (2001) Advanced Drug Delivery Reviews , vol.47 , Issue.2-3 , pp. 165-196
    • Mehnert, W.1    Mader, K.2
  • 127
    • 34548707878 scopus 로고    scopus 로고
    • Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: A retrospective comparison with 30-day sodium stibogluconate monotherapy
    • Melaku, Y., Collin, S.M., Keus, K., Gatluak, F., Ritmeijer, K., Davidson, R.N., 2007. Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy. Am. J. Trop. Med. Hyg. 77, 89-94.
    • (2007) Am. J. Trop. Med. Hyg. , vol.77 , pp. 89-94
    • Melaku, Y.1    Collin, S.M.2    Keus, K.3    Gatluak, F.4    Ritmeijer, K.5    Davidson, R.N.6
  • 128
    • 33750587653 scopus 로고    scopus 로고
    • Interaction between miltefosine and amphotericin B: Consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro
    • DOI 10.1128/AAC.00837-06
    • Ménez, C., Buyse, M., Besnard, M., Farinotti, R., Loiseau, P.M., Barratt, G., 2006a. Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro. Antimicrob. Agents Chemother. 50, 3793-3800. (Pubitemid 44684895)
    • (2006) Antimicrobial Agents and Chemotherapy , vol.50 , Issue.11 , pp. 3793-3800
    • Menez, C.1    Buyse, M.2    Besnard, M.3    Farinotti, R.4    Loiseau, P.M.5    Barratt, G.6
  • 129
    • 30444441660 scopus 로고    scopus 로고
    • Modulation of intestinal barrier properties by miltefosine
    • DOI 10.1016/j.bcp.2005.11.008, PII S0006295205007525
    • Ménez, C., Buyse, M., Chacun, H., Farinotti, R., Barratt, G., 2006b. Modulation of intestinal barrier properties by miltefosine. Biochem. Pharmacol. 71, 486-496. (Pubitemid 43077083)
    • (2006) Biochemical Pharmacology , vol.71 , Issue.4 , pp. 486-496
    • Menez, C.1    Buyse, M.2    Chacun, H.3    Farinotti, R.4    Barratt, G.5
  • 130
    • 34247367684 scopus 로고    scopus 로고
    • Physicochemical characterization of molecular assemblies of miltefosine and amphotericin B
    • DOI 10.1021/mp0601143
    • Ménez, C., Legrand, P., Rosilio, V., Lesieur, S., Barratt, G., 2007. Physicochemical characterization of molecular assemblies of miltefosine and amphotericin B. Mol. Pharm. 4, 281-288. (Pubitemid 46640604)
    • (2007) Molecular Pharmaceutics , vol.4 , Issue.2 , pp. 281-288
    • Menez, C.1    Legrand, P.2    Rosilio, V.3    Lesieur, S.4    Barratt, G.5
  • 131
    • 0025953652 scopus 로고
    • Liposomal amphotericin B (AmBisome): Safety data from a phase II/III clinical trial
    • Meunier, F., Prentice, H.G., Ringdén, O., 1991. Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. J. Antimicrob. Chemother. 28, 83-91.
    • (1991) J. Antimicrob. Chemother. , vol.28 , pp. 83-91
    • Meunier, F.1    Prentice, H.G.2    Ringdén, O.3
  • 132
    • 26944445100 scopus 로고    scopus 로고
    • Reorganization of lipid nanocapsules at air-water interface. Part 2. Properties of the formed surface film
    • DOI 10.1016/j.colsurfb.2005.07.001, PII S0927776505002080
    • Minkov, I., Ivanova, T., Panaiotov, I., Proust, J., Saulnier, P., 2005. Reorganization of lipid nanocapsules at air-water interface: part 2. Properties of the formed surface film. Colloids Surf. B: Biointerfaces 44, 197-203. (Pubitemid 44302094)
    • (2005) Colloids and Surfaces B: Biointerfaces , vol.44 , Issue.4 , pp. 197-203
    • Minkov, I.1    Ivanova, T..2    Panaiotov, I.3    Proust, J.4    Saulnier, P.5
  • 133
    • 84856287418 scopus 로고    scopus 로고
    • Current treatment of leishmaniasis: A review
    • Monzote, L., 2009. Current treatment of leishmaniasis: a review. Open Antimicrob. Agents J. 1, 9-19.
    • (2009) Open Antimicrob. Agents J. , vol.1 , pp. 9-19
    • Monzote, L.1
  • 134
    • 84884160665 scopus 로고    scopus 로고
    • Lipid-based formulations for oral administration of poorly water-soluble drugs
    • Mu, H., Holm, R., Müllertz, A., 2013. Lipid-based formulations for oral administration of poorly water-soluble drugs. Int. J. Pharm., http://dx.doi.org/10.1016/j.ijpharm.2013.03.054.
    • (2013) Int. J. Pharm.
    • Mu, H.1    Holm, R.2    Müllertz, A.3
  • 135
    • 84867262237 scopus 로고    scopus 로고
    • Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review
    • Mukhopadhyay, P., Mishra, R., Rana, D., Kundu, P.P., 2012. Strategies for effective oral insulin delivery with modified chitosan nanoparticles: a review. Progr. Polym. Sci. 37, 1457-1475.
    • (2012) Progr. Polym. Sci. , vol.37 , pp. 1457-1475
    • Mukhopadhyay, P.1    Mishra, R.2    Rana, D.3    Kundu, P.P.4
  • 136
    • 0031658033 scopus 로고    scopus 로고
    • Visceral leishmaniasis in the BALB/c mouse: A comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin B
    • Mullen, A.B., Baillie, A.J., Carter, K.C., 1998. Visceral leishmaniasis in the BALB/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin B. Antimicrob. Agents Chemother. 42, 2722-2725. (Pubitemid 28462922)
    • (1998) Antimicrobial Agents and Chemotherapy , vol.42 , Issue.10 , pp. 2722-2725
    • Mullen, A.B.1    Baillie, A.J.2    Carter, K.C.3
  • 137
    • 34547883880 scopus 로고    scopus 로고
    • Lipid nanoparticles: recent advances
    • DOI 10.1016/j.addr.2007.05.002, PII S0169409X07000750, Lipid Nanoparticles: Recent Advances
    • Müller, R.H., 2007. Lipid nanoparticles: recent advances. Adv. Drug Deliv. Rev. 59, 375-376. (Pubitemid 47260708)
    • (2007) Advanced Drug Delivery Reviews , vol.59 , Issue.6 , pp. 375-376
    • Muller, R.H.1
  • 138
    • 0035937599 scopus 로고    scopus 로고
    • Nanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the future
    • DOI 10.1016/S0169-409X(00)00118-6, PII S0169409X00001186
    • Muller, R.H., Jacobs, C., Kayser, O., 2001. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 47, 3-19. (Pubitemid 32209229)
    • (2001) Advanced Drug Delivery Reviews , vol.47 , Issue.1 , pp. 3-19
    • Muller, R.H.1    Jacobs, C.2    Kayser, O.3
  • 139
    • 0038032150 scopus 로고    scopus 로고
    • Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art
    • DOI 10.1016/S0939-6411(00)00087-4, PII S0939641100000874
    • Muller, R.H., Mader, K., Gohla, S., 2000. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 50, 161-177. (Pubitemid 30326695)
    • (2000) European Journal of Pharmaceutics and Biopharmaceutics , vol.50 , Issue.1 , pp. 161-177
    • Muller, R.H.1    Mader, K.2    Gohla, S.3
  • 140
    • 0342897023 scopus 로고    scopus 로고
    • Nanosuspensions for the formulation of poorly soluble drugs. I. Preparation by a size-reduction technique
    • DOI 10.1016/S0378-5173(97)00311-6, PII S0378517397003116
    • Müller, R.H., Peters, K., 1998. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int. J. Pharm. 160, 229-237. (Pubitemid 28083096)
    • (1998) International Journal of Pharmaceutics , vol.160 , Issue.2 , pp. 229-237
    • Muller, R.H.1    Peters, K.2
  • 141
    • 27544475529 scopus 로고    scopus 로고
    • Advances in leishmaniasis
    • DOI 10.1016/S0140-6736(05)67629-5, PII S0140673605676295
    • Murray, H.W., Berman, J.D., Davies, C.R., Saravia, N.G., 2005. Advances in leishmaniasis. Lancet 366, 1561-1577. (Pubitemid 41540115)
    • (2005) Lancet , vol.366 , Issue.9496 , pp. 1561-1577
    • Murray, H.W.1    Berman, J.D.2    Davies, C.R.3    Saravia, N.G.4
  • 142
    • 42949160050 scopus 로고    scopus 로고
    • Natural products as leads to potential drugs: An old process or the new hope for drug discovery?
    • DOI 10.1021/jm0704090
    • Newman, D.J., 2008. Natural products as leads to potential drugs: an old process or the new hope for drug discovery. J. Med. Chem. 51, 2589-2599. (Pubitemid 351620778)
    • (2008) Journal of Medicinal Chemistry , vol.51 , Issue.9 , pp. 2589-2599
    • Newman, D.J.1
  • 143
    • 0042424608 scopus 로고    scopus 로고
    • Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals
    • DOI 10.1128/AAC.47.9.2781-2787.2003
    • Nieto, J., Alvar, J., Mullen, A.B., Carter, K.C., Rodriguez, C., San Andres, M.I., San Andres, M.D., Baillie, A.J., Gonzalez, F., 2003. Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals. Antimicrob. Agents Chemother. 47, 2781-2787. (Pubitemid 37040248)
    • (2003) Antimicrobial Agents and Chemotherapy , vol.47 , Issue.9 , pp. 2781-2787
    • Nieto, J.1    Alvar, J.2    Mullen, A.B.3    Carter, K.C.4    Rodriguez, C.5    San, A.M.I.6    San, A.M.D.7    Baillie, A.J.8    Gonzalez, F.9
  • 145
    • 0027249951 scopus 로고
    • Practical progress and new drugs for changing patterns of Leishmaniasis
    • DOI 10.1016/0169-4758(93)90231-4
    • Olliaro, P.L., Bryceson, A.D., 1993. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol. Today 9, 323-328. (Pubitemid 23238274)
    • (1993) Parasitology Today , vol.9 , Issue.9 , pp. 323-328
    • Olliaro, P.L.1    Bryceson, A.D.M.2
  • 149
    • 1442349131 scopus 로고    scopus 로고
    • Miltefosine Induces Apoptosis-Like Death in Leishmania donovani Promastigotes
    • DOI 10.1128/AAC.48.3.852-859.2004
    • Paris, C., Loiseau, P.M., Bories, C., Breard, J., 2004. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob. Agents Chemother. 48, 852-859. (Pubitemid 38280335)
    • (2004) Antimicrobial Agents and Chemotherapy , vol.48 , Issue.3 , pp. 852-859
    • Paris, C.1    Loiseau, P.M.2    Bories, C.3    Breard, J.4
  • 150
    • 84856003815 scopus 로고    scopus 로고
    • AmbiOnp: Solid lipid nanoparticles of amphotericin B for oral administration
    • Patel, P.A., Patravale, V.B., 2011. AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration. J. Biomed. Nanotechnol. 7, 632-639.
    • (2011) J. Biomed. Nanotechnol. , vol.7 , pp. 632-639
    • Patel, P.A.1    Patravale, V.B.2
  • 151
    • 0035884996 scopus 로고    scopus 로고
    • Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines
    • Pathak, M.K., Yi, T., 2001. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J. Immunol. 167, 3391-3397. (Pubitemid 32852583)
    • (2001) Journal of Immunology , vol.167 , Issue.6 , pp. 3391-3397
    • Pathak, M.K.1    Yi, T.2
  • 152
    • 0031740361 scopus 로고    scopus 로고
    • Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: Implication in the intracellular drug release in Leishmania major infected mice
    • Paul, M., Durand, R., Boulard, Y., Fusai, T., Fernandez, C., Rivollet, D., Deniau, M., Astier, A., 1998. Physicochemical characteristics of pentamidine-loaded polymethacrylate nanoparticles: implication in the intracellular drug release in Leishmania major infected mice. J. Drug Target. 5, 481-490. (Pubitemid 28499682)
    • (1998) Journal of Drug Targeting , vol.5 , Issue.6 , pp. 481-490
    • Paul, M.1    Durand, R.2    Boulard, Y.3    Fusai, T.4    Fernandez, C.5    Rivollet, D.6    Deniau, M.7    Astier, A.8
  • 153
    • 0030231079 scopus 로고    scopus 로고
    • Enzyme-catalysed polymer modification: Reaction of phenolic compounds with chitosan films
    • DOI 10.1016/0032-3861(96)00338-2
    • Payne, G.F., Chaubal, M.V., Barbari, T.A., 1996. Enzyme-catalysed polymer modification: reaction of phenolic compounds with chitosan films. Polymer 37, 4643-4648. (Pubitemid 126382285)
    • (1996) Polymer , vol.37 , Issue.20 , pp. 4643-4648
    • Payne, G.F.1    Chaubal, M.V.2    Barbari, T.A.3
  • 154
    • 78649907878 scopus 로고    scopus 로고
    • Design and in vitro evaluation of capsaicin transdermal controlled release cubic phase gels
    • Peng, X., Wen, X., Pan, X., Wang, R., Chen, B., Wu, C., 2010. Design and in vitro evaluation of capsaicin transdermal controlled release cubic phase gels. AAPS PharmSciTech 11, 1405-1410.
    • (2010) AAPS PharmSciTech , vol.11 , pp. 1405-1410
    • Peng, X.1    Wen, X.2    Pan, X.3    Wang, R.4    Chen, B.5    Wu, C.6
  • 155
    • 33745253122 scopus 로고    scopus 로고
    • Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
    • DOI 10.1016/j.drup.2006.04.001, PII S1368764606000215
    • Pérez-Victoria, F.J., Sánchez-Canete, M.a.P., Seifert, K., Croft, S.L., Sundar, S., Castanys, S., Gamarro, F., 2006. Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use. Drug Resist. Updat. 9, 26-39. (Pubitemid 43928805)
    • (2006) Drug Resistance Updates , vol.9 , Issue.1-2 , pp. 26-39
    • Perez-Victoria, F.J.1    Sanchez-Canete, M.P.2    Seifert, K.3    Croft, S.L.4    Sundar, S.5    Castanys, S.6    Gamarro, F.7
  • 156
    • 33745253122 scopus 로고    scopus 로고
    • Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
    • DOI 10.1016/j.drup.2006.04.001, PII S1368764606000215
    • Perez-Victoria, F.J., Sanchez-Canete, M.P., Seifert, K., Croft, S.L., Sundar, S., Castanys, S., Gamarro, F., 2006. Mechanisms of experimental resistance of leishmania to miltefosine: implications for clinical use. Drug Resist. Updat. 9, 26-39. (Pubitemid 43928805)
    • (2006) Drug Resistance Updates , vol.9 , Issue.1-2 , pp. 26-39
    • Perez-Victoria, F.J.1    Sanchez-Canete, M.P.2    Seifert, K.3    Croft, S.L.4    Sundar, S.5    Castanys, S.6    Gamarro, F.7
  • 157
    • 53049090855 scopus 로고    scopus 로고
    • Leishmaniasis: Drug resistance and natural products
    • review
    • Polonio, T., Efferth, T., 2008. Leishmaniasis: drug resistance and natural products (review). Int. J. Mol. Med. 22, 277-286.
    • (2008) Int. J. Mol. Med. , vol.22 , pp. 277-286
    • Polonio, T.1    Efferth, T.2
  • 158
    • 33847394968 scopus 로고    scopus 로고
    • Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs
    • DOI 10.1038/nrd2197, PII NRD2197
    • Porter, C.J., Trevaskis, N.L., Charman, W.N., 2007. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6, 231-248. (Pubitemid 46344627)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.3 , pp. 231-248
    • Porter, C.J.H.1    Trevaskis, N.L.2    Charman, W.N.3
  • 159
    • 0035940057 scopus 로고    scopus 로고
    • Intestinal lymphatic drug transport: An update
    • DOI 10.1016/S0169-409X(01)00151-X, PII S0169409X0100151X
    • Porter, C.J.H., Charman, W.N., 2001. Intestinal lymphatic drug transport: an update. Adv. Drug Deliv. Rev. 50, 61-80. (Pubitemid 32727277)
    • (2001) Advanced Drug Delivery Reviews , vol.50 , Issue.1-2 , pp. 61-80
    • Porter, C.J.H.1    Charman, W.N.2
  • 160
    • 33751014029 scopus 로고    scopus 로고
    • Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system
    • DOI 10.1016/j.ejps.2006.04.016, PII S0928098706001151
    • Pouton, C.W., 2006. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 29, 278-287. (Pubitemid 44740131)
    • (2006) European Journal of Pharmaceutical Sciences , vol.29 , Issue.3-4 SPEC. ISS. , pp. 278-287
    • Pouton, C.W.1
  • 163
    • 79959350104 scopus 로고    scopus 로고
    • Oral lipid based drug delivery system (LBDDS): Formulation, characterization and application: A review
    • Rahman, M.A., Harwansh, R., Mirza, M.A., Hussain, S., Hussain, A., 2011. Oral lipid based drug delivery system (LBDDS): formulation, characterization and application: a review. Curr. Drug Deliv. 8, 330-345.
    • (2011) Curr. Drug Deliv. , vol.8 , pp. 330-345
    • Rahman, M.A.1    Harwansh, R.2    Mirza, M.A.3    Hussain, S.4    Hussain, A.5
  • 164
    • 34347324117 scopus 로고    scopus 로고
    • Preparation of liquid-core nanocapsules from poly[(ethylene oxide-co-glycidol)] with multiple hydrophobic linoleates at an oil-water interface and its encapsulation of Pyrene
    • DOI 10.1021/bm0701797
    • Ren, Y., Wang, G., Huang, J., 2007. Preparation of liquid-core nanocapsules from poly[(ethylene oxide)-co-glycidol] with multiple hydrophobic linoleates at an oil-water interface and its encapsulation of pyrene. Biomacromolecules 8, 1873-1880. (Pubitemid 47009966)
    • (2007) Biomacromolecules , vol.8 , Issue.6 , pp. 1873-1880
    • Ren, Y.1    Wang, G.2    Huang, J.3
  • 167
    • 0141890238 scopus 로고    scopus 로고
    • Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats
    • DOI 10.1128/AAC.47.10.3339-3342.2003
    • Risovic, V., Boyd, M., Choo, E., Wasan, K.M., 2003. Effects of lipid-based oral formulations on plasma and tissue amphotericin B concentrations and renal toxicity in male rats. Antimicrob. Agents Chemother. 47, 3339-3342. (Pubitemid 37229601)
    • (2003) Antimicrobial Agents and Chemotherapy , vol.47 , Issue.10 , pp. 3339-3342
    • Risovic, V.1    Boyd, M.2    Choo, E.3    Wasan, K.M.4
  • 168
    • 0032929618 scopus 로고    scopus 로고
    • Poor and unusually prolonged oral absorption of amphotericin B in rats
    • DOI 10.1023/A:1011961322883
    • Robbie, G., Wu, T.-C., Chiou, W., 1999. Poor and unusually prolonged oral absorption of amphotericin B in rats. Pharm. Res. 16, 455-458. (Pubitemid 29162106)
    • (1999) Pharmaceutical Research , vol.16 , Issue.3 , pp. 455-458
    • Robbie, G.1    Wu, T.-C.2    Chiou, W.L.3
  • 170
    • 78651495075 scopus 로고    scopus 로고
    • Studies on 6-chloro-5-(1-naphthyloxy)-2-(trifluoromethyl)-1H- benzimidazole/2-hydroxypropyl-b eta-cyclodextrin association: Characterization, molecular modeling studies, and in vivo anthelminthic activity
    • Rojas-Aguirre, Y., Yepez-Mulia, L., Castillo, I., Lopez-Vallejo, F., Soria-Arteche, O., Hernandez-Campos, A., Castillo, R., Hernandez-Luis, F., 2011. Studies on 6-chloro-5-(1-naphthyloxy)-2-(trifluoromethyl)-1H-benzimidazole/2- hydroxypropyl-b eta-cyclodextrin association: characterization, molecular modeling studies, and in vivo anthelminthic activity. Bioorg. Med. Chem. 19, 789-797.
    • (2011) Bioorg. Med. Chem. , vol.19 , pp. 789-797
    • Rojas-Aguirre, Y.1    Yepez-Mulia, L.2    Castillo, I.3    Lopez-Vallejo, F.4    Soria-Arteche, O.5    Hernandez-Campos, A.6    Castillo, R.7    Hernandez-Luis, F.8
  • 172
    • 83455200692 scopus 로고    scopus 로고
    • Nanocochleate - A new approach in lipid drug delivery
    • Sankar, V., Reddy, Y., 2010. Nanocochleate - a new approach in lipid drug delivery. Int. J. Pharm. Pharm. Sci. 2, 220-223.
    • (2010) Int. J. Pharm. Pharm. Sci. , vol.2 , pp. 220-223
    • Sankar, V.1    Reddy, Y.2
  • 173
    • 19444375996 scopus 로고    scopus 로고
    • Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies
    • DOI 10.1016/j.jconrel.2005.02.010, PII S0168365905000763
    • Sant, V.P., Smith, D., Leroux, J.-C., 2005. Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylateco-methacrylic acid) self-assemblies. J. Control. Release 104, 289-300. (Pubitemid 40724930)
    • (2005) Journal of Controlled Release , vol.104 , Issue.2 , pp. 289-300
    • Sant, V.P.1    Smith, D.2    Leroux, J.-C.3
  • 175
    • 0034605692 scopus 로고    scopus 로고
    • Colloidal carriers for benzathine penicillin G: Nanoemulsions and nanocapsules
    • Santos-Magalhaes, N.S., Pontes, A., Pereira, V.M., Caetano, M.N., 2000. Colloidal carriers for benzathine penicillin G: nanoemulsions and nanocapsules. Int. J. Pharm. 208, 71-80.
    • (2000) Int. J. Pharm. , vol.208 , pp. 71-80
    • Santos-Magalhaes, N.S.1    Pontes, A.2    Pereira, V.M.3    Caetano, M.N.4
  • 176
    • 0036968461 scopus 로고    scopus 로고
    • Quercetin: Critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes
    • Sarkar, S., Mandal, S., Sinha, J., Mukhopadhyay, S., Das, N., Basu, M.K., 2002. Quercetin: critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes. J. Drug Target. 10, 573-578.
    • (2002) J. Drug Target. , vol.10 , pp. 573-578
    • Sarkar, S.1    Mandal, S.2    Sinha, J.3    Mukhopadhyay, S.4    Das, N.5    Basu, M.K.6
  • 177
    • 35848959714 scopus 로고    scopus 로고
    • Alginate/chitosan nanoparticles are effective for oral insulin delivery
    • DOI 10.1007/s11095-007-9367-4
    • Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., Ferreira, D., 2007. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm. Res. 24, 2198-2206. (Pubitemid 350060707)
    • (2007) Pharmaceutical Research , vol.24 , Issue.12 , pp. 2198-2206
    • Sarmento, B.1    Ribeiro, A.2    Veiga, F.3    Sampaio, P.4    Neufeld, R.5    Ferreira, D.6
  • 178
    • 33847337418 scopus 로고    scopus 로고
    • pH-responsive polymeric micelles of poly(ethylene glycol)-b- poly(alkyl(meth)acrylate-co-methacrylic acid): Influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil
    • Satturwar, P., Eddine, M.N., Ravenelle, F., Leroux, J.C., 2007. pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth) acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil. Eur. J. Pharm. Biopharm. 65, 379-387.
    • (2007) Eur. J. Pharm. Biopharm. , vol.65 , pp. 379-387
    • Satturwar, P.1    Eddine, M.N.2    Ravenelle, F.3    Leroux, J.C.4
  • 179
    • 0345643513 scopus 로고    scopus 로고
    • Chitosans as absorption enhancers of poorly absorbable drugs: 3: Influence of mucus on absorption enhancement
    • Schipper, N.G.M., Vårum, K.M., Stenberg, P., Ocklind, G., Lennernäs, H., Artursson, P., 1999. Chitosans as absorption enhancers of poorly absorbable drugs: 3: influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 8, 335-343.
    • (1999) Eur. J. Pharm. Sci. , vol.8 , pp. 335-343
    • Schipper, N.G.M.1    Vårum, K.M.2    Stenberg, P.3    Ocklind, G.4    Lennernäs, H.5    Artursson, P.6
  • 182
    • 34547337720 scopus 로고    scopus 로고
    • Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo
    • DOI 10.1016/j.ijantimicag.2007.05.007, PII S092485790700252X
    • Seifert, K., Perez-Victoria, F.J., Stettler, M., Sanchez-Canete, M.P., Castanys, S., Gamarro, F., Croft, S.L., 2007. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo. Int. J. Antimicrob. Agents 30, 229-235. (Pubitemid 47135625)
    • (2007) International Journal of Antimicrobial Agents , vol.30 , Issue.3 , pp. 229-235
    • Seifert, K.1    Perez-Victoria, F.J.2    Stettler, M.3    Sanchez-Canete, M.P.4    Castanys, S.5    Gamarro, F.6    Croft, S.L.7
  • 184
    • 0035946622 scopus 로고    scopus 로고
    • Cubic phase gels as drug delivery systems
    • DOI 10.1016/S0169-409X(01)00108-9, PII S0169409X01001089
    • Shah, J.C., Sadhale, Y., Chilukuri, D.M., 2001. Cubic phase gels as drug delivery systems. Adv. Drug Deliv. Rev. 47, 229-250. (Pubitemid 32324116)
    • (2001) Advanced Drug Delivery Reviews , vol.47 , Issue.2-3 , pp. 229-250
    • Shah, J.C.1    Sadhale, Y.2    Chilukuri, D.M.3
  • 185
    • 84884145811 scopus 로고    scopus 로고
    • Development of oil-in-water microemulsions for the oral delivery of amphotericin B
    • Silva, A.E., Barratt, G., Chéron, M., Egito, E.S.T., 2013. Development of oil-in-water microemulsions for the oral delivery of amphotericin B. Int. J. Pharm., http://dx.doi.org/10.1016/j.ijpharm.2013.05.044.
    • (2013) Int. J. Pharm.
    • Silva, A.E.1    Barratt, G.2    Chéron, M.3    Egito, E.S.T.4
  • 186
    • 80053087179 scopus 로고    scopus 로고
    • Oral formulation strategies to improve solubility of poorly water-soluble drugs
    • Singh, A., Worku, Z.A., Van den Mooter, G., 2011. Oral formulation strategies to improve solubility of poorly water-soluble drugs. Expert Opin. Drug Deliv. 8, 1361-1378.
    • (2011) Expert Opin. Drug Deliv. , vol.8 , pp. 1361-1378
    • Singh, A.1    Worku, Z.A.2    Van Den Mooter, G.3
  • 188
    • 12444261681 scopus 로고    scopus 로고
    • Challenges and new discoveries in the treatment of leishmaniasis
    • DOI 10.1007/s10156-004-0348-9
    • Singh, S., Sivakumar, R., 2004. Challenges and new discoveries in the treatment of leishmaniasis. J. Infect. Chemother. 10, 307-315. (Pubitemid 40142819)
    • (2004) Journal of Infection and Chemotherapy , vol.10 , Issue.6 , pp. 307-315
    • Singh, S.1    Sivakumar, R.2
  • 191
    • 79961110340 scopus 로고    scopus 로고
    • Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): Biodistribution and toxicity in a mouse model
    • Sivak, O., Gershkovich, P., Lin, M., Wasan, E.K., Zhao, J., Owen, D., Clement, J.G., Wasan, K.M., 2011. Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model. Lipids Health Dis. 10, 135-139.
    • (2011) Lipids Health Dis. , vol.10 , pp. 135-139
    • Sivak, O.1    Gershkovich, P.2    Lin, M.3    Wasan, E.K.4    Zhao, J.5    Owen, D.6    Clement, J.G.7    Wasan, K.M.8
  • 192
    • 0343238502 scopus 로고    scopus 로고
    • Lipid emulsion reduces subacute toxicity of amphotericin B: A histopathological study
    • Souza, L.C., Saldiva, P.H.r.N., Campa, A., 2000. Lipid emulsion reduces subacute toxicity of amphotericin B: a histopathological study. Exp. Toxicol. Pathol. 52, 169-175. (Pubitemid 30313585)
    • (2000) Experimental and Toxicologic Pathology , vol.52 , Issue.2 , pp. 169-175
    • Souza, L.C.1    Saldiva, P.H.N.2    Campa, A.3
  • 193
    • 84861182434 scopus 로고    scopus 로고
    • Rational formulation development and in vitro assessment of SMEDDS for oral delivery of poorly water soluble drugs
    • Sprunk, A., Strachan, C.J., Graf, A., 2012. Rational formulation development and in vitro assessment of SMEDDS for oral delivery of poorly water soluble drugs. Eur. J. Pharm. Sci. 46, 508-515.
    • (2012) Eur. J. Pharm. Sci. , vol.46 , pp. 508-515
    • Sprunk, A.1    Strachan, C.J.2    Graf, A.3
  • 194
    • 0028283641 scopus 로고
    • Overview of amphotericin B colloidal dispersion (Amphocil)
    • Stevens, D.A., 1994. Overview of amphotericin B colloidal dispersion (Amphocil). J. Infect. 28 (Suppl. 1), 45-49.
    • (1994) J. Infect. , vol.28 , Issue.SUPPL. 1 , pp. 45-49
    • Stevens, D.A.1
  • 195
    • 0034780949 scopus 로고    scopus 로고
    • Drug resistance in Indian visceral leishmaniasis
    • DOI 10.1046/j.1365-3156.2001.00778.x
    • Sundar, S., 2001. Drug resistance in Indian visceral leishmaniasis. Trop. Med. Int. Health 6, 849-854. (Pubitemid 33010870)
    • (2001) Tropical Medicine and International Health , vol.6 , Issue.11 , pp. 849-854
    • Sundar, S.1
  • 196
    • 33745224305 scopus 로고    scopus 로고
    • Visceral leishmaniasis - Current therapeutic modalities
    • Sundar, S., Chatterjee, M., 2006. Visceral leishmaniasis - current therapeutic modalities. Indian J. Med. Res. 123, 345-352. (Pubitemid 43905574)
    • (2006) Indian Journal of Medical Research , vol.123 , Issue.3 , pp. 345-352
    • Sundar, S.1    Chatterjee, M.2
  • 201
    • 1042288575 scopus 로고    scopus 로고
    • Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid Formulations
    • DOI 10.1086/380971
    • Sundar, S., Mehta, H., Suresh, A.V., Singh, S.P., Rai, M., Murray, H.W., 2004. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clin. Infect. Dis. 38, 377-383. (Pubitemid 38200114)
    • (2004) Clinical Infectious Diseases , vol.38 , Issue.3 , pp. 377-383
    • Sundar, S.1    Mehta, H.2    Suresh, A.V.3    Singh, S.P.4    Rai, M.5    Murray, H.W.6
  • 202
    • 18944370727 scopus 로고    scopus 로고
    • Availability of miltefosine for the treatment of kala-azar in India
    • Sundar, S., Murray, H.W., 2005. Availability of miltefosine for the treatment of kalaazar in India. Bull. World Health Organ. 83, 394-395. (Pubitemid 40704871)
    • (2005) Bulletin of the World Health Organization , vol.83 , Issue.5 , pp. 394-395
    • Sundar, S.1    Murray, H.W.2
  • 203
    • 36448953526 scopus 로고    scopus 로고
    • Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management
    • Sundar, S., Olliaro, P.L., 2007. Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management. Ther. Clin. Risk Manage. 3, 733-740. (Pubitemid 350162073)
    • (2007) Therapeutics and Clinical Risk Management , vol.3 , Issue.5 , pp. 733-740
    • Sundar, S.1    Olliaro, P.L.2
  • 204
    • 29444452265 scopus 로고    scopus 로고
    • Treatment of visceral leishmaniasis
    • DOI 10.1517/14656566.6.16.2821
    • Sundar, S., Rai, M., 2005. Treatment of visceral leishmaniasis. Expert Opin. Pharmacother. 6, 2821-2829. (Pubitemid 43009545)
    • (2005) Expert Opinion on Pharmacotherapy , vol.6 , Issue.16 , pp. 2821-2829
    • Sundar, S.1    Rai, M.2
  • 205
    • 79958748637 scopus 로고    scopus 로고
    • Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: A randomized study in Bihar, India
    • Sundar, S., Sinha, P.K., Dixon, S.A., Buckley, R., Miller, A.K., Mohamed, K., Al-Banna, M., 2011. Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: a randomized study in Bihar, India. Am. J. Trop. Med. Hyg. 84, 892-900.
    • (2011) Am. J. Trop. Med. Hyg. , vol.84 , pp. 892-900
    • Sundar, S.1    Sinha, P.K.2    Dixon, S.A.3    Buckley, R.4    Miller, A.K.5    Mohamed, K.6    Al-Banna, M.7
  • 207
    • 7444224004 scopus 로고    scopus 로고
    • Oil-in-water lipid emulsions: Implications for parenteral and ocular delivering systems
    • DOI 10.1016/j.plipres.2004.09.001, PII S016378270400027X
    • Tamilvanan, S., 2004. Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Progr. Lipid Res. 43, 489-533. (Pubitemid 39441344)
    • (2004) Progress in Lipid Research , vol.43 , Issue.6 , pp. 489-533
    • Tamilvanan, S.1
  • 208
    • 0032726663 scopus 로고    scopus 로고
    • Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins
    • Tanino, T., Ogiso, T., Iwaki, M., Yamaguchi, T., Kakehi, K., 1999. Release characteristics of endogenous constituents by exposure of small intestine to modified betacyclodextrins. Biol. Pharm. Bull. 22, 1099-1105. (Pubitemid 29507951)
    • (1999) Biological and Pharmaceutical Bulletin , vol.22 , Issue.10 , pp. 1099-1105
    • Tanino, T.1    Ogiso, T.2    Iwaki, M.3    Yamaguchi, T.4    Kakehi, K.5
  • 210
    • 6444223571 scopus 로고    scopus 로고
    • Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India
    • Thakur, C.P., Narayan, S., Ranjan, A., 2004. Epidemiological, clinical & pharmacological study of antimony-resistant visceral leishmaniasis in Bihar, India. Indian J. Med. Res. 120, 166-172. (Pubitemid 39406044)
    • (2004) Indian Journal of Medical Research , vol.120 , Issue.3 , pp. 166-172
    • Thakur, C.P.1    Narayan, S.2    Ranjan, A.3
  • 211
    • 0035478758 scopus 로고    scopus 로고
    • Chitosan and its derivatives as intestinal absorption enhancers
    • DOI 10.1016/S0169-409X(01)00180-6, PII S0169409X01001806
    • Thanou, M., Verhoef, J.C., Junginger, H.E., 2001. Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliv. Rev. 50 (Suppl. 1), S91-S101. (Pubitemid 32905357)
    • (2001) Advanced Drug Delivery Reviews , vol.50 , Issue.SUPPL. 1
    • Thanou, M.1    Verhoef, J.C.2    Junginger, H.E.3
  • 213
    • 33845566719 scopus 로고    scopus 로고
    • Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles
    • DOI 10.1016/j.ijpharm.2006.08.013, PII S0378517306006600
    • Tiyaboonchai, W., Limpeanchob, N., 2007. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int. J. Pharm. 329, 142-149. (Pubitemid 44937518)
    • (2007) International Journal of Pharmaceutics , vol.329 , Issue.1-2 , pp. 142-149
    • Tiyaboonchai, W.1    Limpeanchob, N.2
  • 214
    • 18744405403 scopus 로고    scopus 로고
    • Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis
    • Tyagi, R., Lala, S., Verma, A.K., Nandy, A.K., Mahato, S.B., Maitra, A., Basu, M.K., 2005. Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis. J. Drug Target. 13, 161-171.
    • (2005) J. Drug Target. , vol.13 , pp. 161-171
    • Tyagi, R.1    Lala, S.2    Verma, A.K.3    Nandy, A.K.4    Mahato, S.B.5    Maitra, A.6    Basu, M.K.7
  • 215
    • 58149464297 scopus 로고    scopus 로고
    • Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres
    • Veerareddy, P.R., Vobalaboina, V., Ali, N., 2009. Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheres. J. Drug Target. 17, 140-147.
    • (2009) J. Drug Target. , vol.17 , pp. 140-147
    • Veerareddy, P.R.1    Vobalaboina, V.2    Ali, N.3
  • 216
    • 0016166315 scopus 로고
    • The influence of pH, Ca2+ and protein on the thermotropic behaviour of the negatively charged phospholipid, phosphatidylglycerol
    • Verkleij, A.J., de Kruyff, B., Ververgaert, P.H., Tocanne, J.F., van Deenen, L.L., 1974. The influence of pH, Ca2+ and protein on the thermotropic behaviour of the negatively charged phospholipid, phosphatidylglycerol. Biochim. Biophys. Acta 339, 432-437.
    • (1974) Biochim. Biophys. Acta , vol.339 , pp. 432-437
    • Verkleij, A.J.1    De Kruyff, B.2    Ververgaert, P.H.3    Tocanne, J.F.4    Van Deenen, L.L.5
  • 217
    • 79957676878 scopus 로고    scopus 로고
    • Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles
    • Verma, R.K., Pandya, S., Misra, A., 2011. Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles. J. Biomed. Nanotechnol. 7, 118-120.
    • (2011) J. Biomed. Nanotechnol. , vol.7 , pp. 118-120
    • Verma, R.K.1    Pandya, S.2    Misra, A.3
  • 219
    • 64149117052 scopus 로고    scopus 로고
    • Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans
    • Wasan, E.K., Bartlett, K., Gershkovich, P., Sivak, O., Banno, B., Wong, Z., Gagnon, J., Gates, B., Leon, C.G., Wasan, K.M., 2009. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int. J. Pharm. 372, 76-84.
    • (2009) Int. J. Pharm. , vol.372 , pp. 76-84
    • Wasan, E.K.1    Bartlett, K.2    Gershkovich, P.3    Sivak, O.4    Banno, B.5    Wong, Z.6    Gagnon, J.7    Gates, B.8    Leon, C.G.9    Wasan, K.M.10
  • 221
    • 0036411713 scopus 로고    scopus 로고
    • The role of lymphatic transport in enhancing oral protein and peptide drug delivery
    • DOI 10.1081/DDC-120014573
    • Wasan, K.M., 2002. The role of lymphatic transport in enhancing oral protein and peptide drug delivery. Drug Dev. Ind. Pharm. 28, 1047-1058. (Pubitemid 35278830)
    • (2002) Drug Development and Industrial Pharmacy , vol.28 , Issue.9 , pp. 1047-1058
    • Wasan, K.M.1
  • 223
    • 0018653707 scopus 로고
    • 2+-induced fusion of phospholipid vesicles monitored by mixing of aqueous contents
    • DOI 10.1038/281690a0
    • Wilschut, J., Papahadjopoulos, D., 1979. Calcium induced fusion of phospholipid vesicles monitored by mixing of aqueous contents. Nature 281, 690-692. (Pubitemid 10249051)
    • (1979) Nature , vol.281 , Issue.5733 , pp. 690-692
    • Wilschut, J.1    Papahadjopoulos, D.2
  • 224
    • 78650180318 scopus 로고    scopus 로고
    • Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs
    • Wu, C., Wang, Z., Zhi, Z., Jiang, T., Zhang, J., Wang, S., 2011. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs. Int. J. Pharm. 403, 162-169.
    • (2011) Int. J. Pharm. , vol.403 , pp. 162-169
    • Wu, C.1    Wang, Z.2    Zhi, Z.3    Jiang, T.4    Zhang, J.5    Wang, S.6
  • 226
    • 77955317693 scopus 로고    scopus 로고
    • Dual responsive copolymer micelles for drug controlled release
    • Yang, L., Guo, C., Jia, L., Liang, X., Liu, C., Liu, H., 2010. Dual responsive copolymer micelles for drug controlled release. J. Colloid Interf. Sci. 350, 22-29.
    • (2010) J. Colloid Interf. Sci. , vol.350 , pp. 22-29
    • Yang, L.1    Guo, C.2    Jia, L.3    Liang, X.4    Liu, C.5    Liu, H.6
  • 227
    • 80053504272 scopus 로고    scopus 로고
    • Optimization of the preparation process for an oral phytantriol-based amphotericin B cubosomes
    • Article ID 308016
    • Yang, Z., Peng, X., Tan, Y., Chen, M., Zhu, X., Feng, M., Xu, Y., Wu, C., 2011. Optimization of the preparation process for an oral phytantriol-based amphotericin B cubosomes. J. Nanomater. 2011, Article ID 308016, 10 pages.
    • (2011) J. Nanomater. , vol.2011 , pp. 10
    • Yang, Z.1    Peng, X.2    Tan, Y.3    Chen, M.4    Zhu, X.5    Feng, M.6    Xu, Y.7    Wu, C.8
  • 229
    • 13844267381 scopus 로고    scopus 로고
    • Drug delivery by lipid cochleates
    • DOI 10.1016/S0076-6879(05)91018-5
    • Zarif, L., 2005. Drug delivery by lipid cochleates. Methods Enzymol. 391, 314-329. (Pubitemid 40254043)
    • (2005) Methods in Enzymology , vol.391 , Issue.SPEC. ISS. , pp. 314-329
    • Zarif, L.1
  • 231
    • 0034037471 scopus 로고    scopus 로고
    • Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model
    • DOI 10.1128/AAC.44.6.1463-1469.2000
    • Zarif, L., Graybill, J.R., Perlin, D., Najvar, L., Bocanegra, R., Mannino, R.J., 2000b. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Antimicrob. Agents Chemother. 44, 1463-1469. (Pubitemid 30340780)
    • (2000) Antimicrobial Agents and Chemotherapy , vol.44 , Issue.6 , pp. 1463-1469
    • Zarif, L.1    Graybill, J.R.2    Perlin, D.3    Najvar, L.4    Bocanegra, R.5    Mannino, R.J.6
  • 233
    • 84874304861 scopus 로고    scopus 로고
    • Porous starch based self-assembled nano-delivery system improvesthe oral absorption of lipophilic drug
    • Zhang, Z., Huang, J., Jiang, S., Liu, Z., Gu, W., Yu, H., Li, Y., 2013. Porous starch based self-assembled nano-delivery system improvesthe oral absorption of lipophilic drug. Int. J. Pharm. 444, 162-168.
    • (2013) Int. J. Pharm. , vol.444 , pp. 162-168
    • Zhang, Z.1    Huang, J.2    Jiang, S.3    Liu, Z.4    Gu, W.5    Yu, H.6    Li, Y.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.